These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1329900)

  • 1. Inhibition of platelet aggregation by the cAMP-phosphodiesterase inhibitor, cilostamide, may not be associated with activation of cAMP-dependent protein kinase.
    Nishikawa M; Komada F; Morita K; Deguchi K; Shirakawa S
    Cell Signal; 1992 Jul; 4(4):453-63. PubMed ID: 1329900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity.
    Sudo T; Tachibana K; Toga K; Tochizawa S; Inoue Y; Kimura Y; Hidaka H
    Biochem Pharmacol; 2000 Feb; 59(4):347-56. PubMed ID: 10644042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of cyclic AMP generation in the inhibition of respiratory burst by 2-phenyl-4-quinolone (YT-1) in rat neutrophils.
    Wang JP; Raung SL; Huang LJ; Kuo SC
    Biochem Pharmacol; 1998 Dec; 56(11):1505-14. PubMed ID: 9827585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KT5926, a potent and selective inhibitor of myosin light chain kinase.
    Nakanishi S; Yamada K; Iwahashi K; Kuroda K; Kase H
    Mol Pharmacol; 1990 Apr; 37(4):482-8. PubMed ID: 2325635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of phospholipase A2 (PLA2)-dependent Ca2+ signaling in smooth muscle by cAMP- and cGMP-dependent protein kinases. Inhibitory phosphorylation of PLA2 by cyclic nucleotide-dependent protein kinases.
    Murthy KS; Makhlouf GM
    J Biol Chem; 1998 Dec; 273(51):34519-26. PubMed ID: 9852121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet effects of caffeic acid due to Ca(2＋) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation.
    Lee DH; Kim HH; Cho HJ; Bae JS; Yu YB; Park HJ
    J Atheroscler Thromb; 2014; 21(1):23-37. PubMed ID: 24088646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intracellular actions of antiplatelet drugs which affect cyclic AMP metabolism in platelets--their effects on Ca2+ mobilization and protein phosphorylation in human platelets].
    Nishikawa M; Saitoh M; Deguchi K; Shirakawa S
    Rinsho Byori; 1990 Jul; Suppl 86():54-61. PubMed ID: 2172597
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of the cAMP-elevating agents cilostamide, cilostazol and forskolin on the phosphorylation of Akt and GSK-3beta in platelets.
    Hayashi H; Sudo T
    Thromb Haemost; 2009 Aug; 102(2):327-35. PubMed ID: 19652884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Aminochromones block human platelet aggregation by inhibiting cyclic AMP-dependent phosphodiesterase leading to reduced platelet phospholipase C activity.
    Benjamin CW; Lin AH; Morris J; Wishka DG; Gorman RR
    J Pharmacol Exp Ther; 1993 Apr; 265(1):457-62. PubMed ID: 7682615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
    Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
    Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imidazoquinoline derivatives: potent inhibitors of platelet cAMP phosphodiesterase which elevate cAMP levels and activate protein kinase in platelets.
    Seiler S; Gillespie E; Arnold AJ; Brassard CL; Meanwell NA; Fleming JS
    Thromb Res; 1991 Apr; 62(1-2):31-42. PubMed ID: 1649498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic nucleotide phosphodiesterase inhibitors prevent aggregation of human platelets by raising cyclic AMP and reducing cytoplasmic free calcium mobilization.
    Lanza F; Beretz A; Stierlé A; Corre G; Cazenave JP
    Thromb Res; 1987 Mar; 45(5):477-84. PubMed ID: 3035738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forskolin potentiates G-CSF-induced proliferation of a murine myeloblastic leukemia cell line.
    Kobayashi K; Nishikawa M; Omay SB; Toyoda H; Deguchi K; Shirakawa S
    Leuk Res; 1994 Feb; 18(2):111-7. PubMed ID: 7509014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of platelet cyclic AMP level by thromboxane A2/prostaglandin H2 receptor agonists.
    Ishikawa Y; Ogawa A
    Thromb Res; 1991 Dec; 64(6):667-76. PubMed ID: 1665927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of the inhibitory guanine-nucleotide-binding protein as a possible mechanism of inhibition by protein kinase C of agonist-induced Ca2+ mobilization in human platelet.
    Yatomi Y; Arata Y; Tada S; Kume S; Ui M
    Eur J Biochem; 1992 May; 205(3):1003-9. PubMed ID: 1576985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of ONO-3708 and S-145 on shape change and aggregation of rabbit platelets induced by STA2.
    Li BY; Qiao GF; Sun JP; Gao YR; Li WH
    Zhongguo Yao Li Xue Bao; 1996 Jul; 17(4):345-8. PubMed ID: 9812720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel inhibition of platelet-activating factor-induced protein phosphorylation and serotonin release by K-252a, a new inhibitor of protein kinases, in rabbit platelets.
    Yamada K; Iwahashi K; Kase H
    Biochem Pharmacol; 1988 Mar; 37(6):1161-6. PubMed ID: 3128296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic phosphorylation of the focal adhesion-associated vasodilator-stimulated phosphoprotein in intact human platelets in response to cGMP- and cAMP-elevating platelet inhibitors.
    Nolte C; Eigenthaler M; Horstrup K; Hönig-Liedl P; Walter U
    Biochem Pharmacol; 1994 Oct; 48(8):1569-75. PubMed ID: 7980622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
    Manns JM; Brenna KJ; Colman RW; Sheth SB
    Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.